← Back to headlines
West Pharmaceutical Signals Strong 2026 Financial Outlook
West Pharmaceutical has provided a 2026 financial outlook, projecting revenues between $3.295 billion and $3.35 billion and adjusted EPS of $8.40-$8.75, driven by momentum in HVP components.
23 Apr, 16:02 — 23 Apr, 16:02
Sources
Showing 1 of 1 sources



